Press releases

ORYZON receives the INNOVATIVE SME seal from the Spanish Ministry of Science and Innovation

ORYZON reports financial results and corporate update for quarter ended December 31, 2023

ORYZON to provide corporate progress updates at several events in February-March

ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Borderline Personality Disorder on January 25, 2024

ORYZON Announces Topline Results from Phase IIb PORTICO study of vafidemstat in Borderline Personality Disorder (BPD)

ORYZON to provide corporate progress updates at several events in January

ORYZON awarded with a grant for ORY-4001 from the ALS Association in the U.S.

ORYZON announces a New Financing through a Convertible Bond Program for a total amount of up to €45 million

ORYZON announces Last Patient Last Visit in its Phase IIb PORTICO study for Borderline Personality Disorder (BPD)

ORYZON to provide corporate progress updates at several events in November